Zotepine is an atypical antipsychotic medication primarily prescribed for the treatment of schizophrenia and other psychotic disorders in adult patients. It helps manage symptoms such as hallucinations, delusions, and disorganized thinking by modulating neurotransmitter activity in the brain. Available in tablet form with strengths including 25 mg, 50 mg, and 100 mg, zotepine requires careful dosing and monitoring due to its potential side effects. It is considered a prescription-only medicine and should be used under medical supervision.

Zotepine acts mainly by antagonising dopamine D2 receptors and serotonin 5-HT2A receptors in the central nervous system. This dual action helps to restore the balance of neurotransmitters, which is often disrupted in schizophrenia. By reducing dopamine activity in certain brain pathways, zotepine alleviates positive symptoms such as hallucinations and delusions, while serotonin receptor antagonism may improve negative symptoms and cognitive deficits.

This medication is prescribed for patients diagnosed with schizophrenia or related psychotic conditions who require antipsychotic therapy. Treatment with zotepine can improve long-term outcomes by reducing relapse rates and improving social functioning when combined with psychosocial interventions.

Patients on zotepine should be regularly monitored for side effects such as sedation, extrapyramidal symptoms, and metabolic changes. Dose adjustments may be necessary based on clinical response and tolerability. It is important to adhere strictly to the prescribed regimen and consult a healthcare provider before making any changes.

Schizophrenia

Zotepine is used to treat schizophrenia by managing symptoms such as hallucinations, delusions, and thought disorders.

Psychotic Disorders

It is also prescribed for other psychotic conditions requiring antipsychotic treatment.

Symptom Control

Effectively reduces positive symptoms of psychosis such as hallucinations and delusions.

Improved Cognitive Function

May improve cognitive deficits and negative symptoms due to serotonin receptor antagonism.

Reduced Relapse Risk

Long-term use can decrease the frequency of psychotic relapses.

Flexible Dosing

Available in multiple tablet strengths for tailored treatment.

Common Side Effects

Sedation, dry mouth, dizziness, weight gain, and mild extrapyramidal symptoms such as tremors or stiffness.

Serious Side Effects

Neuroleptic malignant syndrome, tardive dyskinesia, severe extrapyramidal symptoms, significant metabolic disturbances, and blood dyscrasias. Immediate medical attention is required if these occur.

This list is not exhaustive. Patients should report any unusual symptoms to their doctor promptly.

Take zotepine exactly as prescribed by your healthcare provider to ensure safety and effectiveness.

• Swallow tablets whole with water; do not crush or chew.
• Take at the same time each day to maintain consistent blood levels.
• Do not stop taking the medication abruptly without consulting your doctor.
• Dose adjustments will be made based on response and side effects.

Zotepine primarily acts by blocking dopamine D2 receptors in the brain, reducing excessive dopaminergic activity associated with psychotic symptoms. It also antagonises serotonin 5-HT2A receptors, which may help improve negative symptoms and cognitive function. This dual receptor blockade contributes to its efficacy as an atypical antipsychotic.

• Take zotepine exactly as prescribed without skipping doses.
• Avoid alcohol to reduce risk of increased sedation.
• Do not drive or operate heavy machinery until you know how the medicine affects you.
• Report any unusual movements, muscle stiffness, or fever to your doctor immediately.
• Keep all follow-up appointments for monitoring side effects and treatment response.

• Store at room temperature between 20°C to 25°C.
• Keep tablets in their original packaging to protect from light and moisture.
• Keep out of reach of children.
• Do not use after the expiry date printed on the package.

No significant food interactions have been reported with zotepine. Patients may take it with or without food as advised by their doctor.

Other CNS depressants (SEVERE): Increased sedation and respiratory depression risk. Avoid concurrent use or monitor closely. Your doctor may adjust doses.

Antihypertensives (MODERATE): May enhance hypotensive effects. Blood pressure monitoring is recommended. Your doctor may modify therapy.

Drugs metabolised by CYP450 enzymes (MODERATE): Potential for altered zotepine levels. Monitoring for efficacy and side effects is advised. Your doctor may adjust dose.

Liver impairment (SEVERE): Reduced metabolism may increase side effects. Dose adjustment and monitoring required. Your doctor may perform liver function tests.

Kidney impairment (MODERATE): Clearance may be affected; caution advised. Your doctor may adjust dose accordingly.

Cardiovascular disease (CAUTION): Risk of orthostatic hypotension and arrhythmias. Monitor blood pressure and ECG. Your doctor may modify treatment.

Overdose of zotepine primarily affects the central nervous system and cardiovascular system, causing severe sedation, hypotension, respiratory depression, and possible coma. Early symptoms include extreme drowsiness, confusion, and irregular heartbeat. In case of suspected overdose, seek emergency medical attention immediately. Supportive care and monitoring in a hospital setting are essential.

If a dose is missed, take it as soon as you remember unless it is near the time for the next dose. Do not double the dose to make up for a missed one. Continue with the regular dosing schedule and consult your doctor if unsure.